echemi logo
Product
  • Product
  • Supplier
  • Inquiry
    Home > Biochemistry News > Natural Products News > Progress in research on novel immunosuppressive active heteroditerpenoids

    Progress in research on novel immunosuppressive active heteroditerpenoids

    • Last Update: 2021-04-28
    • Source: Internet
    • Author: User
    Search more information of high quality chemicals, good prices and reliable suppliers, visit www.echemi.com










    Natural products with novel structures and diverse activities are an inexhaustible source for the discovery of small-molecule drug lead compounds.
    However, the difficulty of confirming the configuration of complex natural products and the low content of them have become the main problem in the continuous advancement of new lead compounds.
    The Isodon plant of the Lamiaceae family is one of the important medicinal plant groups in China.
    It has the functions of clearing away heat, detoxifying, anti-bacterial, anti-inflammatory, and anti- bioon.
    com/course_video/chang-fei-bian-ma-RNA-yu-zhong-liu959063.
    html">tumor .
    The research team of the important group phytochemistry and function research team of Kunming Institute of Botany, Chinese Academy of Sciences, Puno Baima Tenzin's research group has long been committed to the discovery of novel lead compounds in this genus of plants and the development of innovative drugs.

    In recent years, the research team has carried out systematic research on the morphological specific species of the genus Isodon scoparius, and has achieved a series of results: (1) Discovery of a novel rearrangement antipode-Helimanane Type diterpene scopariusins ​​A–C (Org.
    Lett.
    2013, 15, 314-317); (2) a novel heteroditerpene scopariusic acid ( Org.
    Lett.
    2013, 15, 4446-4449); (3) discovered novel heteroditerpene scopariusicides A and B with asymmetric cyclobutane fragments, and completed the biomimetic synthesis of scopariusicide A (Org.
    Lett.
    2015, 17, 6062-6065).

    In 2012, the research team discovered for the first time a heteroditerpene (-)-isoscopariusin A with a novel 6/6/4 all-carbon skeleton from the fragrant tea plant, which has significant immunosuppressive activity on T lymphocytes ( IC50 = 0.
    36 uM).
    However, because the sample is an oily substance, the ideal crystal form cannot be obtained, which makes it difficult to confirm its absolute configuration by X-ray single crystal diffraction analysis; in addition, due to the low content of the sample in the plant, it is difficult to meet the requirements for further development.
    The demand for pharmacological research.


    In order to solve the above problems, the research team has carried out chemical synthesis research on it since 2015, and has successively developed two generations of synthetic routes.
    Using commercially available sclareolide as the starting material, a 12-step gram-level synthesis has been achieved.
    The key reactions involved: 1) Cobalt-catalyzed olefin isomerization reaction to prepare trisubstituted olefins; 2) Stereoselective synthesis of a-aryl groups based on the intermolecular [2 + 2] cycloaddition reaction of ketene imine salts Substituted cyclobutanone bioon.
    com/tags/%E4%B8%AD%E9%97%B4%E4%BD%93/" target="_blank">intermediates ; 3) The fully substituted cyclobutane skeleton was further constructed through surface-selective homologation reactions; 4) Nickel-catalyzed cross-coupling and carbodiimide-mediated esterification reactions were carried out, respectively.
    Perform side chain assembly.
    The above research work not only achieved the gram-level synthesis of this new type of heteroditerpenoids, and determined the absolute configuration of the target molecule, but also laid a research foundation for the discovery of lead compounds with immunosuppressive activity.
    (bioon.
    com" target="_blank">Bioon.
    com)
    Natural products with novel structures and diverse activities are an inexhaustible source for the discovery of small-molecule drug lead compounds.
    However, the difficulty of confirming the configuration of complex natural products and the low content of them have become the main problem in the continuous advancement of new lead compounds.
    The Isodon plant of the Lamiaceae family is one of the important medicinal plant groups in China.
    It has the functions of clearing away heat, detoxifying, anti-bacterial, anti-inflammatory, and anti- bioon.
    com/course_video/chang-fei-bian-ma-RNA-yu-zhong-liu959063.
    html">tumor .
    The research team of the important group phytochemistry and function research team of Kunming Institute of Botany, Chinese Academy of Sciences, Puno Baima Tenzin's research group has long been committed to the discovery of novel lead compounds in this genus of plants and the development of innovative drugs.
    bioon.
    com/course_video/chang-fei-bian-ma-RNA-yu-zhong-liu959063.
    html">Tumor


    In recent years, the research team has carried out systematic research on the morphological specific species of the genus Isodon scoparius, and has achieved a series of results: (1) Discovery of a novel rearrangement antipode-Helimanane Type diterpene scopariusins ​​A–C (Org.
    Lett.
    2013, 15, 314-317); (2) a novel heteroditerpene scopariusic acid ( Org.
    Lett.
    2013, 15, 4446-4449); (3) discovered novel heteroditerpene scopariusicides A and B with asymmetric cyclobutane fragments, and completed the biomimetic synthesis of scopariusicide A (Org.
    Lett.
    2015, 17, 6062-6065).


    In 2012, the research team discovered for the first time a heteroditerpene (-)-isoscopariusin A with a novel 6/6/4 all-carbon skeleton from the fragrant tea plant, which has significant immunosuppressive activity on T lymphocytes ( IC50 = 0.
    36 uM).
    However, because the sample is an oily substance, the ideal crystal form cannot be obtained, which makes it difficult to confirm its absolute configuration by X-ray single crystal diffraction analysis; in addition, due to the low content of the sample in the plant, it is difficult to meet the requirements for further development.
    The demand for pharmacological research.


    In order to solve the above problems, the research team has carried out chemical synthesis research on it since 2015, and has successively developed two generations of synthetic routes.
    Using commercially available sclareolide as the starting material, a 12-step gram-level synthesis has been achieved.
    The key reactions involved: 1) Cobalt-catalyzed olefin isomerization reaction to prepare trisubstituted olefins; 2) Stereoselective synthesis of a-aryl groups based on the intermolecular [2 + 2] cycloaddition reaction of ketene imine salts Substituted cyclobutanone bioon.
    com/tags/%E4%B8%AD%E9%97%B4%E4%BD%93/" target="_blank">intermediates ; 3) The fully substituted cyclobutane skeleton was further constructed through surface-selective homologation reactions; 4) Nickel-catalyzed cross-coupling and carbodiimide-mediated esterification reactions were carried out, respectively.
    Perform side chain assembly.
    The above research work not only achieved the gram-level synthesis of this new type of heteroditerpenoids, and determined the absolute configuration of the target molecule, but also laid a research foundation for the discovery of lead compounds with immunosuppressive activity.
    (bioon.
    com" target="_blank">Bioon.
    com)
    bioon.
    com/tags/%E4%B8%AD%E9%97%B4%E4%BD%93/" target="_blank">Intermediatebioon.
    com" target="_blank">
    This article is an English version of an article which is originally in the Chinese language on echemi.com and is provided for information purposes only. This website makes no representation or warranty of any kind, either expressed or implied, as to the accuracy, completeness ownership or reliability of the article or any translations thereof. If you have any concerns or complaints relating to the article, please send an email, providing a detailed description of the concern or complaint, to service@echemi.com. A staff member will contact you within 5 working days. Once verified, infringing content will be removed immediately.

    Contact Us

    The source of this page with content of products and services is from Internet, which doesn't represent ECHEMI's opinion. If you have any queries, please write to service@echemi.com. It will be replied within 5 days.

    Moreover, if you find any instances of plagiarism from the page, please send email to service@echemi.com with relevant evidence.